{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:15:17Z","timestamp":1783185317679,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,13]]},"DOI":"10.7759\/cureus.12689","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T02:25:52Z","timestamp":1610591152000},"source":"Crossref","is-referenced-by-count":4,"title":["New Onset Non-Convulsive Status Epilepticus Despite Cefepime Renal Dose Adjustment"],"prefix":"10.7759","author":[{"given":"Mosunmoluwa","family":"Oyenuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi","family":"Oyenuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omotola","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2006.03.019","article-title":"Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli","volume":"56","author":"Labombardi VJ","year":"2006","unstructured":"Labombardi VJ, Rojtman A, Tran K. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Diagn Microbiol Infect Dis. 2006, 56:313-315. 10.1016\/j.diagmicrobio.2006.03.019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref2","article-title":"Cefepime: a new fourth-generation cephalosporin","volume":"51","author":"Okamoto MP","year":"1994","unstructured":"Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA. Cefepime: a new fourth-generation cephalosporin. Am J Hosp Pharm. 1994, 51:463-542.","journal-title":"Am J Hosp Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne LE","year":"2017","unstructured":"Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017, 21:276. 10.1186\/s13054-017-1856-1","journal-title":"Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14581\/jer.13008","article-title":"Cefepime-induced non-convulsive status epilepticus (NCSE)","volume":"3","author":"Kim A","year":"2013","unstructured":"Kim A, Kim JE, Paek YM, et al.. Cefepime-induced non-convulsive status epilepticus (NCSE). J Epilepsy Res. 2013, 3:39-41. 10.14581\/jer.13008","journal-title":"J Epilepsy Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2174\/187152408786848139","article-title":"Cefepime-induced neurotoxicity","volume":"8","author":"Bragatti JA","year":"2008","unstructured":"Bragatti JA. Cefepime-induced neurotoxicity. Cent Nerv Syst Agents Med Chem. 2008, 8:229-233. 10.2174\/187152408786848139","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.9.2265","article-title":"Cefepime-related neurotoxicity in a haemodialysis patient","volume":"14","author":"Wong KM","year":"1999","unstructured":"Wong KM, Chan WK, Chan YH, Li CS. Cefepime-related neurotoxicity in a haemodialysis patient. Nephrol Dial Transplant. 1999, 14:2265-6. 10.1093\/ndt\/14.9.2265","journal-title":"Nephrol Dial Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm713","article-title":"The neurotoxicity and safety of treatment with cefepime in patients with renal failure","volume":"23","author":"Sonck J","year":"2008","unstructured":"Sonck J, Laureys G, Verbeelen D. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant. 2008, 23:966-70. 10.1093\/ndt\/gfm713","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/cc13094","article-title":"Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy","volume":"17","author":"Fugate JE","year":"2013","unstructured":"Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013, 17:264. 10.1186\/cc13094","journal-title":"Crit Care"},{"key":"ref9","article-title":"Renal failure is a risk factor for cefepime-induced encephalopathy","volume":"21","author":"Garces EO","year":"2008","unstructured":"Garces EO, de Anzambuja MFA, da Silva D, Bragatti JA, Jacoby T, Saldanha Thom\u00e9 F. Renal failure is a risk factor for cefepime-induced encephalopathy. J Nephrol. 2008, 21:526-3.","journal-title":"J Nephrol"},{"key":"ref10","unstructured":"FDA drug safety communication. cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment. (2016). Accessed: December 7, 2020: http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm309661.htm."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill MF","year":"2008","unstructured":"Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother. 2008, 42:1843-1850. 10.1345\/aph.1L307","journal-title":"Ann Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx170","article-title":"Characterizing cefepime neurotoxicity: a systematic review","volume":"4","author":"Appa AA","year":"2017","unstructured":"Appa AA, Jain R, Rakita RM, Hakimian S, Pottinger PS. Characterizing cefepime neurotoxicity: a systematic review. Open Forum Infect Dis. 2017, 4:170. 10.1093\/ofid\/ofx170","journal-title":"Open Forum Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.09.010","article-title":"Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function","volume":"8","author":"Maganti R","year":"2006","unstructured":"Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav. 2006, 8:312-314. 10.1016\/j.yebeh.2005.09.010","journal-title":"Epilepsy Behav"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks012","article-title":"Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports","volume":"67","author":"Durand-Maugard C","year":"2012","unstructured":"Durand-Maugard C, Lemaire-Hurtel AS, Gras-Champel V, et al.. Blood and CSF monitoring of cefepime-induced neurotoxicity: nine case reports. J Antimicrob Chemother. 2012, 67:1297-9. 10.1093\/jac\/dks012","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-019-00682-y","article-title":"Clinical, electroencephalographic features and prognostic factors of cefepime-induced neurotoxicity: a retrospective study","volume":"31","author":"Li HT","year":"2019","unstructured":"Li HT, Lee CH, Wu T, et al.. Clinical, electroencephalographic features and prognostic factors of cefepime-induced neurotoxicity: a retrospective study. Neurocrit Care. 2019, 31:329-337. 10.1007\/s12028-019-00682-y","journal-title":"Neurocrit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116674","article-title":"Prevalence and clinical correlates of non-convulsive status epilepticus in elderly patients with acute confusional state: a systematic literature review","volume":"410","author":"Manfredonia F","year":"2020","unstructured":"Manfredonia F, Saturno E, Lawley A, Gasverde S, Cavanna AE. Prevalence and clinical correlates of non-convulsive status epilepticus in elderly patients with acute confusional state: a systematic literature review. J Neurol Sci. 2020, 410:116674. 10.1016\/j.jns.2020.116674","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.581308","article-title":"Cefepime neurotoxicity despite renal adjusted dosing","volume":"43","author":"Gangireddy VG","year":"2011","unstructured":"Gangireddy VG, Mitchell LC, Coleman T. Cefepime neurotoxicity despite renal adjusted dosing. Scand J Infect Dis. 2011, 43:827-829. 10.3109\/00365548.2011.581308","journal-title":"Scand J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piw022","article-title":"Cefepime-induced neurotoxicity despite dose adjustment for renal disease: a brief report and review of the literature","volume":"6","author":"Lindsay H","year":"2017","unstructured":"Lindsay H, Gruner S, Brackett J. Cefepime-induced neurotoxicity despite dose adjustment for renal disease: a brief report and review of the literature. J Pediatric Infect Dis Soc. 2017, 6:199-201. 10.1093\/jpids\/piw022","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz476","article-title":"A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients","volume":"75","author":"Lau C","year":"2020","unstructured":"Lau C, Marriott D, Gould M, Andresen D, Reuter SE, Penm J. A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients. J Antimicrob Chemother. 2020, 75:718-725. 10.1093\/jac\/dkz476","journal-title":"J Antimicrob Chemother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study","volume":"23","author":"Huwyler T","year":"2017","unstructured":"Huwyler T, Lenggenhager L, Abbas M, et al.. Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study. Clin Microbiol Infect. 2017, 23:454-459. 10.1016\/j.cmi.2017.01.005","journal-title":"Clin Microbiol Infect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/48011-new-onset-non-convulsive-status-epilepticus-despite-cefepime-renal-dose-adjustment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:12Z","timestamp":1707506892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/48011-new-onset-non-convulsive-status-epilepticus-despite-cefepime-renal-dose-adjustment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,13]]}}}